Imricor Medical Systems (IMR) AGM 2025 summary

Opening remarks and agenda

• Meeting opened with introductions of directors, CFO, audit firm representative, and company secretary, confirming a quorum was present and business could proceed.

• Stakeholders and proxies were informed about voting procedures and the opportunity to ask questions throughout the meeting, with instructions for submitting questions and voting online.

Financial performance review

• Recent financing of AUD 70 million has strengthened the balance sheet, enabling accelerated progress toward strategic goals and a pipeline of new activated sites.

• Noted significant value creation for patients, physicians, hospitals, payers, and investors as commercialization scales globally.

Board and executive committee updates

• Introduction of directors Mark Tibbles, Anita Misal, Peter McGregor, Jeffrey Layton, CFO Jonathan Gut, and company secretary Kobe Li.

• Steve Wedan continues as Executive Chair, President, and CEO, with a leadership team including Jonathon Gut (CFO) and several non-executive directors.

• Board composition reaffirmed with re-election and appointments of directors, including Peter McGregor and Dr Jeffrey Leighton.